Advanced Medicine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

An insight into the research fuelling developments for universal cancer immunotherapies

Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

High growth predictions for regenerative medicine are exciting, but what if current capacity can’t keep pace?

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

Better data brings new advances in our knowledge of genetics. PacBio VP Neil Ward explains how pharmacogenomics will accelerate precision medicine.

CellProthera is demonstrating the safety and efficacy of a cell therapy approach to regenerating tissue following myocardial infarction

Libmeldy gene therapy is used for the first time in the UK outside of a clinical trial.

A video interview addressing the need for training in cell and gene therapy manufacturing.